| Hans-Günter Meyer-Thompson | Hepatitiden
HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
Bregenzer A, Krismer C, Wendel S, Roser P, Fux CA.
Swiss Med Wkly. 2022 Dec 9;152:40009. doi: 10.57187/smw.2022.40009. PMID: 36509421.